MDS Podcast Hot topic: The gut microbiome in Parkinson’s
In this special Hot Topics episode, Dr. Filip Scheperjans discusses what we know and what we don’t yet know about the gut microbiome in Parkinson’s disease, theories of influencing...
Stay up to date on novel, clinically-relevant research findings in Parkinson’s disease and other movement disorders.
All Episodes
MDS Podcast Pathological Validation of 2022 MSA Criteria
Sara Schaefer discusses with Dr. Eduardo de Pablo-Fernandez his recent paper in Movement Disorders providing retrospective pathological validation of the 2022 MDS MSA Criteria using specimens from the Queens...
MDS Podcast Walking through the falls: understanding gait with wearable sensors in Parkinson’s disease
In this paper, Dr. Vrustangkumar Shah and colleagues evaluated gait in patients with Parkinson’s disease in the lab and in real life, with and without levodopa through wearable sensors....
MDS Podcast Targeting alpha synuclein in early Parkinson’s disease. Clinical trials and future perspectives
Two clinical trials with antibodies targeting alpha synuclein in early Parkinson’s disease have been published in the New England Journal of Medicine. Anthony Lang and Gennaro Pagano, the first...
MDS Podcast Dystonia Series: Current and future approaches to treatment of dystonia
In part 5 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Jill Ostrem about current and future approaches to treatment of dystonia.
MDS Podcast Dystonia Series: Unraveling the neural routes of dystonia
In part 4 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Anna Sadnicka on the neural roots of dystonia.
MDS Podcast Machine learning for drug repurposing: A novel approach to find new treatments for Parkinson’s disease
Dr. Matarazzo interviews Émeline Courtois about the recently published article on machine learning approach to discover marketed drugs that could have an impact on the development of Parkinson’s disease....
MDS Podcast Dystonia Series: Genetic landscape of dystonia
In part 3 of the Dystonia Special Series, Dr. Francesca Morgante interviews Prof. Carolyn Sue on the Genetic landscape of dystonia.
MDS Podcast Clozapine in Parkinson’s disease: Why, when and how?
Clozapine is a antipsychotic drug that has been marketed for decades. In this interview, Dr. Friedman shares his thoughts on its utility in Parkinson’s disease along with some practical...